2-methyl-5-[(e)-(2-phenylindol-3-ylidene)methyl]-3-(1,3,4-thiadiazol-2-yl)imidazol-4-ol (CHEM321334)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-08-30 03:10:41 UTC | ||||||||
| Update Date | 2026-08-30 03:10:41 UTC | ||||||||
| Accession Number | CHEM321334 | ||||||||
| Identification | |||||||||
| Common Name | 2-methyl-5-[(e)-(2-phenylindol-3-ylidene)methyl]-3-(1,3,4-thiadiazol-2-yl)imidazol-4-ol | ||||||||
| Class | Small Molecule | ||||||||
| Description | Not Available | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type | Not Available | ||||||||
| Chemical Structure |  | ||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C21H15N5OS | ||||||||
| Average Molecular Mass | Not Available | ||||||||
| Monoisotopic Mass | 385.100 g/mol | ||||||||
| CAS Registry Number | Not Available | ||||||||
| IUPAC Name | 2-methyl-5-[(e)-(2-phenylindol-3-ylidene)methyl]-3-(1,3,4-thiadiazol-2-yl)imidazol-4-ol | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | CC1=NC(=C(N1C2=NN=CS2)O)C=C3C4=CC=CC=C4N=C3C5=CC=CC=C5 | ||||||||
| InChI Identifier | InChI=1S/C21H15N5OS/c1-13-23-18(20(27)26(13)21-25-22-12-28-21)11-16-15-9-5-6-10-17(15)24-19(16)14-7-3-2-4-8-14/h2-12,27H,1H3/b16-11+ | ||||||||
| InChI Key | NJQFSCXESWNHDR-LFIBNONCSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra |
| ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||
